Related news from
Wed, 24 Apr 2024 13:30:10 +0000	Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy? Based on the average brokerage recommendation (ABR), DexCom (DXCM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Tue, 23 Apr 2024 13:29:00 +0000	DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
Tue, 23 Apr 2024 10:14:00 +0000	Boston Scientific, Dexcom and Edwards next as earnings season rolls on J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.
Mon, 22 Apr 2024 13:16:00 +0000	Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics Beyond analysts' top -and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Mon, 22 Apr 2024 13:01:00 +0000	Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom Vertiv, Align Technology and DexCom are part of the Zacks Investment Ideas article.
Mon, 22 Apr 2024 12:00:14 +0000	DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to the...
Fri, 19 Apr 2024 18:39:27 +0000	Even IBD 50 Medical Products Stocks Don't All Look Healthy In This Sick Market Dexcom stock reversed on Friday and fell below a buy point. But one of these medical stocks is still in a buy zone.
Fri, 19 Apr 2024 12:30:51 +0000	Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week Dexcom stock is in a buy zone ahead of earnings next week. Shares rallied after the company launched a prescription-free glucose monitoring device.
Fri, 19 Apr 2024 11:00:00 +0000	3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback Long-term investors are often well-served to buy stocks amid bouts of weakness.
Thu, 18 Apr 2024 12:26:00 +0000	Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Tue, 16 Apr 2024 23:00:52 +0000	EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM) EVP Strategy and Corporate Development Matthew Dolan has sold 1,990 shares of DexCom Inc (NASDAQ:DXCM) on April 15, 2024, according to a recent SEC filing.
Tue, 16 Apr 2024 08:34:00 +0000	Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.
Tue, 16 Apr 2024 08:13:07 +0000	14 Best 52-Week High Stocks To Invest In Now This article delves into the examination of the 14 best 52-week high stocks to buy now. To explore more such companies that meet comparable criteria, go directly to 5 Best 52-Week High Stocks To Buy Now. The outlook for 2024 is positive for the economy and the stock market. Market conditions improved significantly in Q4 […]
Mon, 15 Apr 2024 22:15:16 +0000	DexCom (DXCM) Stock Moves -1.16%: What You Should Know In the latest trading session, DexCom (DXCM) closed at $134.56, marking a -1.16% move from the previous day.
Mon, 15 Apr 2024 15:16:00 +0000	3 Medical Instruments Stocks to Buy Amid Improving Industry Trends The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
Mon, 15 Apr 2024 14:54:00 +0000	DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management DexCom (DXCM) and MD Revolution collaborate to integrate Dexcom's continuous glucose monitoring systems with MD Revolution's remote care management platform to boost remote diabetes management.
Fri, 12 Apr 2024 12:00:36 +0000	Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit Metabolic health is all the rage, helped by the advent of weight-loss drugs and continuous glucose monitors. Can they change disease forever?
Thu, 11 Apr 2024 13:40:10 +0000	Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Here is how DexCom (DXCM) and Anika Therapeutics (ANIK) have performed compared to their sector so far this year.
Wed, 10 Apr 2024 23:00:33 +0000	Insider Sell: DexCom Inc (DXCM) President, CEO and Chairman Kevin Sayer Sells 49,633 Shares On April 8, 2024, Kevin Sayer, President, CEO and Chairman of DexCom Inc (NASDAQ:DXCM), sold 49,633 shares of the company.
Wed, 10 Apr 2024 20:00:00 +0000	Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In The latest employment figures saw indices rise. However, losses earlier in the week persist as investors remain cautious of the Fed’s stance on interest rate adjustments. Amid this climate, it’s essential to highlight a few potential Nasdaq stocks to sell. They could represent a shift from the buoyant sentiment a month ago when the Nasdaq and broader markets reached successive record highs. While returns have been strong year-to-date (YTD), some analysts argue that exuberance may be fading as th